leisure time -WSS

leisure time

author：focus 2025-10-02 17:22:24 - browse：57

Traffic on the Longfellow Bridge and the Kendall Square skyline are seen. -- health coverage from STAT — Michael Dwyer/AP

Around this time three years ago, while most of us navigated pandemic life, real estate developers across Greater Boston looked to life-science laboratories, and saw dollar signs.

The white-collar office workers who’d long filled downtown towers were largely staying home (unless they worked in commercial real estate). The future of cities had rarely been murkier.

But many biotech companies, like Cambridge’s Moderna, were busier than ever, and growing fast. Life-science companies, and the lab buildings that house them, looked like a sure bet for investors. Money poured in to drug companies by the billions — from venture capitalists, the stock market, the National Institutes of Health. And big real estate investors followed, launching a wave of speculative lab development all over Greater Boston.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Let's speed up science by embracing open access publishing

entertainment

WSS

Woman returns to dialysis after doctors remove transplanted pig kidney

How Medicaid coverage policies for immigrants impact new moms

The Pandemic Treaty must support building strong health systems

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

FDA approves RSV monoclonal antibody for infants, toddlers

HIV drugs protect against transmission, even in unprotected sex

focus

leisure time

hotspot

Bright Health sells Medicare Advantage business to Molina

Biden tests positive for Covid

Medicare proposal to cover medical devices draws a mixed reaction

The Pandemic Treaty must support building strong health systems

Heart attack and stroke risk calculators need revising

AI can’t replace a physician’s gut feeling

23andMe had bad news about my health. I wish a person had delivered it

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Alkermes shareholders re

FDA's Pazdur wants cancer trials to range beyond China alone

focus

Medicare has a new plan to address drug shortages

ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Medicare to cover more brain scans for Alzheimer’s patients

WHO calls for emergency meeting on new China virus, as cases spread

Custom gene therapy hints at new path for rare disease treatments

entertainment

focus

explore

hotspot